The Quality Lowdown: Warning Letters, Nitrosamine Recalls And Sen. Warren's Generics Manufacturing Plan

Manufacturers warned on quality basics like testing and keeping records and reminded about nitrosamine deadlines; Senator Elizabeth Warren clarifies government drug manufacturing idea.

The Quality Lowdown

A trio of warning letters, some analysis and advice related to the discovery of nitrosamine impurities in various medications, and a clarification by one of the US presidential candidates on her plan for public-sector pharmaceutical manufacturing are featured in this latest edition of the Quality Lowdown.

The warning letters to over-the-counter drug manufacturers on three continents highlighted comparable types of failures in basic drug good manufacturing...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance